Healthpeak Properties (DOC) Q3 2024 earnings summary

Executive summary

• Completed merger with Physicians Realty Trust, acquiring 299 outpatient medical buildings and issuing 162 million shares, significantly expanding the outpatient medical segment and portfolio scale.

• Earnings per share have grown by mid-double digits over the last three years, with four key levers for continued growth: merger synergies, leasing momentum, outpatient medical business strength, and disciplined capital allocation.

• Reported Q3 2024 net income of $0.12 per share, Nareit FFO of $0.44, FFO as Adjusted of $0.45, and AFFO of $0.41 per share; Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of 4.1%.

• Guidance was raised for the third time this year, reflecting outperformance in leasing, same-store operations, and merger synergies.

• Focus remains on healthcare real estate, with a diversified portfolio and strong investment-grade balance sheet.

Financial highlights

• Q3 2024 net income: $85.7M ($0.12/share), up from $64.0M in Q3 2023; Q3 2024 Nareit FFO: $315.8M ($0.44/share); FFO as Adjusted: $320.8M ($0.45/share); AFFO: $289.5M ($0.41/share).

• Total revenues for Q3 2024 were $700.4 million, up from $556.2 million in Q3 2023.

• Total portfolio same-store growth reached 4.1% for the quarter.

• Over 85% of FFO translates to AFFO, supporting a dividend payout ratio trending toward 75%.

• Cash flows from operations for the nine months ended September 30, 2024 were $787.0 million, up $62.0 million year-over-year.

Outlook and guidance

• 2024 diluted EPS guidance raised to $0.40–$0.42; Nareit FFO to $1.61–$1.63; FFO as Adjusted to $1.79–$1.81; AFFO to $1.56–$1.58.

• Same-store guidance tightened and increased by 50 bps to 3.5%–4.5%.

• Merger synergies for 2024 now expected to reach $50 million, 25% above initial forecast.

• Management expects cash flows from operations, available cash, and financing activities to be adequate for the next 12 months and foreseeable future.

• An investor presentation focusing on competitive positioning and growth drivers is planned for early November.